Vitamin Products Antitrust Litigation
(Indirect Purchasers)
BASF Corp., Daiichi Pharmaceuticals Co., Ltd., Eisai Co., Ltd., Aventis Animal Nutrition S.A., Hoffman-La Roche, Inc., Roche Vitamins Inc., and Takeda Chemical Industries Ltd. allegedly conspired to fix, raise, maintain, or stabilize the prices of, and allocate volumes, markets, or customers for, vitamin products. Indirect vitamin products, which were involved in this case, are found in products not directly bought from the vitamin manufacturer. Some of these vitamins include vitamin A, astaxanthin, vitamin B1 (thiamin), vitamin B2 (riboflavin), vitamin B4 (choline chloride), vitamin B5 (calpan), vitamin B6, vitamin B9 (folic acid), vitamin B12 (cyanocobalamine pharma), beta-carotene, vitamin C, canthaxanthin, vitamin E, and vitamin H (biotin). Also included in the lawsuit were products containing or constituting (in whole or in part) any of the above vitamins, as well as products derived from animals that consumed any of the above vitamins. We assisted potential claimants in filing for settlement.
